Nanomolar Inhibitors of Trypanosoma brucei RNA Triphosphatase

被引:17
|
作者
Smith, Paul [1 ,5 ]
Ho, C. Kiong [2 ,3 ]
Takagi, Yuko [3 ]
Djaballah, Hakim [4 ]
Shuman, Stewart [1 ]
机构
[1] Sloan Kettering Inst, Program Mol Biol, New York, NY USA
[2] Univ Tsukuba, Fac Med, Dept Infect Biol, Tsukuba, Ibaraki, Japan
[3] SUNY Buffalo, Dept Biol Sci, Buffalo, NY USA
[4] Mem Sloan Kettering Canc Ctr, High Throughput Screening Core Facil, 1275 York Ave, New York, NY 10021 USA
[5] Fordham Univ, Dept Chem, Bronx, NY 10458 USA
来源
MBIO | 2016年 / 7卷 / 01期
基金
美国国家科学基金会;
关键词
INDUCIBLE EXPRESSION SYSTEM; CAPPING ENZYME LEF4; MUTATIONAL ANALYSIS; ACTIVE-SITE; NUCLEOSIDE TRIPHOSPHATASE; STRUCTURAL DETERMINANTS; CRYSTAL-STRUCTURE; DRUG TARGET; YEAST; APPARATUS;
D O I
10.1128/mBio.00058-16
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Eukaryal taxa differ with respect to the structure and mechanism of the RNA triphosphatase (RTPase) component of the mRNA capping apparatus. Protozoa, fungi, and certain DNA viruses have a metal-dependent RTPase that belongs to the triphosphate tunnel metalloenzyme (TTM) superfamily. Because the structures, active sites, and chemical mechanisms of the TTM-type RTPases differ from those of mammalian RTPases, the TTM RTPases are potential targets for antiprotozoal, antifungal, and antiviral drug discovery. Here, we employed RNA interference (RNAi) knockdown methods to show that Trypanosoma brucei RTPase Cet1 (TbCet1) is necessary for proliferation of procyclic cells in culture. We then conducted a high-throughput biochemical screen for small-molecule inhibitors of the phosphohydrolase activity of TbCet1. We identified several classes of chemicals-including chlorogenic acids, phenolic glycopyranosides, flavonoids, and other phenolics-that inhibit TbCet1 with nanomolar to low-micromolar 50% inhibitory concentrations (IC(50)s). We confirmed the activity of these compounds, and tested various analogs thereof, by direct manual assays of TbCet1 phosphohydrolase activity. The most potent nanomolar inhibitors included tetracaffeoylquinic acid, 5-galloylgalloylquinic acid, pentagalloylglucose, rosmarinic acid, and miquelianin. TbCet1 inhibitors were less active (or inactive) against the orthologous TTM-type RTPases of mimivirus, baculovirus, and budding yeast (Saccharomyces cerevisiae). Our results affirm that a TTM RTPase is subject to potent inhibition by small molecules, with the caveat that parallel screens against TTM RTPases from multiple different pathogens may be required to fully probe the chemical space of TTM inhibition. IMPORTANCE The stark differences between the structure and mechanism of the RNA triphosphatase (RTPase) component of the mRNA capping apparatus in pathogenic protozoa, fungi, and viruses and those of their metazoan hosts highlight RTPase as a target for anti-infective drug discovery. Protozoan, fungal, and DNA virus RTPases belong to the triphosphate tunnel metalloenzyme family. This study shows that a protozoan RTPase, TbCet1 from Trypanosoma brucei, is essential for growth of the parasite in culture and identifies, via in vitro screening of chemical libraries, several classes of potent small-molecule inhibitors of TbCet1 phosphohydrolase activity.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] An RNA ligase essential for RNA editing and survival of the bloodstream form of Trypanosoma brucei
    Schnaufer, A
    Panigrahi, AK
    Panicucci, B
    Igo, RP
    Salavati, R
    Stuart, K
    SCIENCE, 2001, 291 (5511) : 2159 - 2162
  • [32] Functional complementation of Trypanosoma brucei RNA in vitro editing with recombinant RNA ligase
    Gao, GH
    Simpson, AM
    Kang, XD
    Rogers, K
    Nebohacova, M
    Li, F
    Simpson, L
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (13) : 4712 - 4717
  • [33] In Vitro and in Vivo Activity of Multitarget Inhibitors against Trypanosoma brucei
    Yang, Gyongseon
    Zhu, Wei
    Wang, Yang
    Huang, Guozhong
    Byun, Soo Young
    Choi, Gahee
    Li, Kai
    Huang, Zhuoli
    Docampo, Roberto
    Oldfield, Eric
    No, Joo Hwan
    ACS INFECTIOUS DISEASES, 2015, 1 (08): : 388 - 398
  • [34] Discovery of Potent and Selective Inhibitors of Trypanosoma brucei Ornithine Decarboxylase
    Smithson, David C.
    Lee, Jeongmi
    Shelat, Anang A.
    Phillips, Margaret A.
    Guy, R. Kiplin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (22) : 16771 - 16781
  • [35] Kinetics of methionine transport and metabolism by Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense
    Goldberg, B
    Rattendi, D
    Lloyd, D
    Yarlett, N
    Bacchi, CJ
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 377 (01) : 49 - 57
  • [36] Triazinyl derivatives that are potent inhibitors of glucose transport in Trypanosoma brucei
    Bayele, HK
    PARASITOLOGY RESEARCH, 2001, 87 (11) : 911 - 914
  • [37] In vitro and in vivo activity of multitarget inhibitors against Trypanosoma brucei
    Wang, Yang
    Zhu, Wei
    Yang, Gyongseon
    Huang, Guozhong
    Byun, Sooyoung
    Choi, Gahee
    Li, Kai
    Huang, Zhuoli
    Docampo, Roberto
    Oldfield, Eric
    No, Joo Hwan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [38] SPECIFIC INHIBITORS FOR THE GLYCOLYTIC-ENZYMES OF TRYPANOSOMA-BRUCEI
    TRINQUIER, M
    PERIE, J
    CALLENS, M
    OPPERDOES, F
    WILLSON, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (11) : 1423 - 1427
  • [39] Computer-Aided Discovery of Trypanosoma brucei RNA-Editing Terminal Uridylyl Transferase 2 Inhibitors
    Demir, Oezlem
    Labaied, Mehdi
    Merritt, Chris
    Stuart, Ken
    Amaro, Rommie E.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2014, 84 (02) : 131 - 139
  • [40] Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei
    Roster, Colm P.
    Lavigne, Danielle
    Milanes, Jillian E.
    Knight, Emily
    Anderson, Heidi D.
    Pizarro, Sabrina
    Harding, Elijah M.
    Morris, Meredith T.
    Yan, Victoria C.
    Pham, Cong-Dat
    Muller, Florian
    Kwain, Samuel
    Rees, Kerrick C.
    Dominy, Brian
    Whitehead, Daniel C.
    Uddin, Md Nasir
    Millward, Steven W.
    Morris, James C.
    PATHOGENS, 2023, 12 (11):